Evid Invest
Who owns PVLAWhat PVLA owns — n/a

Who owns PALVELLA THERAPEUTICS, INC.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of PVLA from SEC Form 13F filings across 199 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 199 institutions disclosed 14.6M shares of PALVELLA THERAPEUTICS, INC. worth $2.01B — about 100.3% of shares outstanding; the largest disclosed holder is JENNISON ASSOCIATES LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

199

13F holders

$2.01B

value, 2026 filers

100.3%

of shares outstanding (14.6M sh)

34

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of PVLA's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1JENNISON ASSOCIATES LLC1.1M$152.0M0.1%7.6%+14.7%
2MONTANOVA CAPITAL, LLC1.0M$144.1M3.4%7.2%-8.0%
3BlackRock, Inc.989,691$136.5M0.0%6.8%+7.8%
4Frazier Life Sciences Management, L.P.882,400$121.7M3.0%6.1%0.0%
5First Light Asset Management, LLC734,086$101.3M6.0%5.1%-4.9%
6STATE STREET CORP624,879$86.2M0.0%4.3%-4.3%
7BVF INC/IL607,149$83.7M2.8%4.2%-9.8%
8PRICE T ROWE ASSOCIATES INC /MD/591,995$81.7M0.0%4.1%-7.3%
9VANGUARD CAPITAL MANAGEMENT LLC540,712$74.6M0.0%3.7%+5.2%
10WESTFIELD CAPITAL MANAGEMENT CO LPNEW396,045$54.6M0.2%2.7%new
11FEDERATED HERMES, INC.332,422$45.9M0.1%2.3%-23.2%
12MARSHALL WACE, LLP329,799$45.5M0.0%2.3%+11463.8%
13Invesco Ltd.312,729$43.1M0.0%2.2%+829.3%
14GEODE CAPITAL MANAGEMENT, LLC311,596$43.0M0.0%2.1%+12.8%
15FRONTIER CAPITAL MANAGEMENT CO LLC276,272$38.1M0.4%1.9%-42.3%
16PRIMECAP MANAGEMENT CO/CA/268,609$37.0M0.0%1.8%+4.9%
17ALLIANCEBERNSTEIN L.P.254,969$35.2M0.0%1.8%+0.7%
18Woodline Partners LP250,517$34.6M0.1%1.7%-21.1%
19EVENTIDE ASSET MANAGEMENT, LLC231,484$31.9M0.4%1.6%0.0%
20ORBIMED ADVISORS LLC229,860$31.7M0.6%1.6%-21.4%
21EMERALD ADVISERS, LLC229,404$31.6M0.9%1.6%0.0%
22Siren, L.L.C.207,485$28.6M0.7%1.4%-19.4%
23MPM BIOIMPACT LLC197,633$27.3M2.0%1.4%-3.1%
24WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCNEW195,070$26.9M0.1%1.3%new
25Bellevue Group AG155,000$21.4M0.4%1.1%0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.